Can You Transfer From Sequence to Another GLP-1 Provider? 2026: Complete Switching Guide | Luma Health
Switching Guides

Can You Transfer From Sequence to Another GLP-1 Provider? 2026: Complete Switching Guide

📅 Updated June 2026 🕒 8 min read ✓ Medically Reviewed ⚡ Action-Oriented Guide
Direct Answer

Yes — you can leave Sequence (WW Clinic) and continue GLP-1 treatment with another provider. GLP-1 prescriptions are not "transferred" between telehealth providers the way retail pharmacy prescriptions sometimes are. Instead, your new provider completes a fresh clinical evaluation and issues a new prescription at your current dose. No restart, no re-titration if you've been tolerating your current dose well.

There are two Sequence-specific considerations that make this switch slightly more complex than switching between compounded providers: (1) Sequence typically prescribes brand-name Wegovy or Ozempic through insurance, while most cash-pay alternatives prescribe compounded semaglutide — a different product with the same active molecule; and (2) canceling Sequence requires canceling both the WW Clinic medication subscription and the WW membership separately.

Three Things That Make Switching From Sequence Different

Sequence / WW Clinic — Switching Nuances

1. You're likely on brand-name, not compounded
Sequence/WW Clinic's model is built around brand-name Wegovy (semaglutide) or Ozempic (semaglutide) obtained through insurance prior authorization. Most cash-pay GLP-1 providers (including Luma Health) prescribe compounded semaglutide. These are the same active pharmaceutical molecule at equivalent doses, but compounded semaglutide is not an FDA-approved finished drug product — it's prepared per prescription by a licensed 503A pharmacy. Understand this distinction before switching: you're not "transferring" a brand-name prescription; you're moving to a compounded alternative.
2. Your insurance pathway ends when you leave Sequence
If your insurance was covering Wegovy or Ozempic through Sequence's prior authorization, that coverage is specific to the prescribing relationship with Sequence's clinicians. When you move to a new provider, the new provider would need to initiate a new prior authorization process if you want to stay on brand-name through insurance. Most patients leaving Sequence for cost reasons move to cash-pay compounded semaglutide — this means losing insurance coverage and paying out-of-pocket.
3. Cancel BOTH WW Clinic AND WW membership
Sequence/WW Clinic bundles two subscriptions: the GLP-1 medication access (WW Clinic) and a WeightWatchers membership. These may be billed separately and require separate cancellation steps. Some patients who thought they'd canceled Sequence discovered the WW membership continued billing. Before initiating any switch, contact WW Clinic support and confirm in writing: (a) how to cancel the medication access component, (b) how to cancel the WW membership component, and (c) the effective date of each cancellation.

Brand-Name Wegovy vs Compounded Semaglutide: What Changes

Sequence / WW Clinic — Brand-Name Pathway

  • ● Brand-name Wegovy or Ozempic from Novo Nordisk
  • ● FDA-approved finished drug product
  • ● Dispensed through retail pharmacy with insurance
  • ● Prefilled auto-injector pens (Wegovy) or cartridge pens (Ozempic)
  • ● Cost via insurance: potentially $0–$25/mo with NovoCare card
  • ● Cash-pay if insurance denied: ~$1,349/mo (Wegovy)
  • ● WW membership bundled: $23–$45/mo additional

★ Luma Health — Compounded Pathway

  • ★ Compounded semaglutide — same active molecule
  • ★ Prepared per prescription by VialsRX (TX #35264)
  • ★ Vial + syringe format (not an auto-injector pen)
  • ★ $197/mo flat — all doses — no insurance needed
  • ★ No WW membership required
  • ★ Not FDA-approved as a finished drug product
  • ★ Clinical services through Wasef Health, PC

The active pharmaceutical ingredient — semaglutide — is the same in both. The clinical efficacy data (STEP 1: 14.9% average weight loss at 68 weeks) applies to the molecule. The practical differences: compounded semaglutide comes in a multi-dose vial with syringes rather than prefilled auto-injector pens, it's not manufactured by Novo Nordisk, and it's not covered by insurance. For patients moving from brand-name insurance coverage to cash-pay compounded, this is a meaningful lifestyle change (learning to draw up and inject from a vial) worth understanding before switching.

Step-by-Step: How to Transfer From Sequence to Luma Health

⚠ Don't Cancel Sequence Before Your New Medication Ships Canceling Sequence ends your brand-name medication prescription. Do not initiate cancellation until your Luma Health medication has a confirmed shipping date — ideally until it's in hand. A gap between Wegovy injections and compounded semaglutide injections will interrupt your treatment continuity.
1

Know your current medication details

Note whether you're on Wegovy or Ozempic, your current weekly dose (e.g., 1.7 mg/week or 2.4 mg/week for Wegovy), and how long you've been at that dose. Take a photo of your current pen label. You'll provide this to Luma Health during intake so your Wasef Health, PC provider can match your current dose in the compounded format.

2

Learn the vial + syringe injection technique before switching

Compounded semaglutide from VialsRX comes in a multi-dose vial with syringes rather than the prefilled auto-injector pens used by Wegovy and Ozempic. If you've only used auto-injectors, take 10 minutes to watch a subcutaneous injection tutorial on YouTube before receiving your first compounded vial. The technique is straightforward — draw the prescribed volume from the vial with a syringe, inject subcutaneously in the abdomen, thigh, or upper arm — but the mechanical process is different from clicking an auto-injector pen. Luma Health provides administration instructions with every shipment.

3

Complete Luma Health's intake with 2–3 weeks of Sequence medication remaining

Start the intake at start.mylumahealth.com when you have at least 2 to 3 weekly doses of your current medication remaining. Specify your current semaglutide dose (the Wegovy dose number maps directly to semaglutide mg/week — e.g., Wegovy 1.7 mg/week = 1.7 mg/week semaglutide) and how long you've been stable at that dose. Your Wasef Health, PC provider will prescribe compounded semaglutide at the equivalent dose.

4

Wait for VialsRX shipping confirmation before canceling anything

After Wasef Health, PC approves your intake (typically 24–48 hours), VialsRX prepares and ships within 5 to 10 business days with a tracking number. Wait until you have a confirmed tracking number — ideally until the medication is in hand — before initiating any Sequence cancellation steps.

5

Cancel BOTH Sequence components separately

Contact WW Clinic support to cancel your medication access subscription. Then separately verify and cancel your WeightWatchers membership if it was bundled. Get written email confirmation of both cancellations with effective dates. If you're mid-billing-cycle, you typically retain access through the period paid. Check your plan for any commitment period or early cancellation obligations.

6

Inject from your VialsRX vial at your next scheduled weekly dose

When your Luma Health medication arrives, draw up your equivalent weekly dose from the vial and inject subcutaneously at your normal weekly schedule. Your body doesn't know whether the semaglutide molecule came from a Novo Nordisk Wegovy pen or a VialsRX compounding vial — the pharmacological effect at equivalent doses is the same. Continue at your current dose without any step-down.

Frequently Asked Questions

Can you actually transfer a GLP-1 prescription from Sequence to another provider?

Not in the traditional pharmacy transfer sense. A GLP-1 prescription from Sequence/WW Clinic is issued by Sequence's clinical team and is specific to their prescribing relationship with you. When you switch to a new telehealth provider, you complete a new clinical evaluation and the new provider's clinicians issue a fresh prescription. There's no paper prescription to "transfer" — just information (your current medication, dose, and duration) that you provide to your new provider so they can prescribe at the appropriate level. This process takes 24 to 48 hours for provider review at Luma Health, followed by 5 to 10 business days for VialsRX to prepare and ship.

Will I need to restart my semaglutide titration when switching from Sequence?

No, if you've been stable at your current dose. Provide your current Wegovy/Ozempic dose and how long you've been at it during the Luma Health intake. Your Wasef Health, PC provider will prescribe compounded semaglutide at the equivalent dose — no step-down, no re-titration from the beginning. The only scenario where your new provider might suggest a dose adjustment is if you've had persistent side effects at your current dose that haven't resolved, which would be a clinical discussion at intake.

What's the difference between Wegovy and compounded semaglutide?

Same active pharmaceutical ingredient (semaglutide) at equivalent doses — the clinical effect on GLP-1 receptors, appetite suppression, and weight loss is identical. The differences: Wegovy is an FDA-approved finished drug product manufactured by Novo Nordisk in prefilled auto-injector pens, subject to full manufacturing regulatory oversight. Compounded semaglutide is prepared per prescription by a licensed 503A compounding pharmacy (VialsRX, TX #35264 for Luma Health), dispensed in a multi-dose vial with syringes, and is not itself FDA-approved as a finished drug product. Compounded semaglutide is not covered by insurance and costs significantly less cash-pay than brand Wegovy.

Do I need to cancel my WW membership separately from WW Clinic?

Yes — this is critical. Sequence/WW Clinic bundles two components that may require separate cancellation actions: the WW Clinic prescription access and the WeightWatchers membership. Patients have reported canceling one and not the other, resulting in continued billing for the surviving component. Before initiating any switch, contact WW Clinic support directly and ask them to confirm exactly which components are active on your account and the specific process to cancel each. Get written email confirmation of both cancellations with the effective date for each. This dual-cancellation requirement is one of the more common friction points for patients leaving Sequence.

Will I lose my weight loss results if I switch from Sequence?

No. Your weight loss results are a function of continuous GLP-1 receptor activation from the semaglutide molecule — not from the specific platform managing your prescription. As long as you continue weekly injections at your current dose without a significant gap, your progress is fully preserved. The STEP 4 trial (Rubino et al., JAMA 2021) demonstrated this clearly: patients who discontinued semaglutide regained most of the weight they'd lost, while patients who continued treatment maintained their results. Continued medication is what protects your progress — the provider name on the prescription is irrelevant to the pharmacology.

What should I do if I want to keep brand-name Wegovy coverage after leaving Sequence?

Brand-name Wegovy coverage through insurance requires a prior authorization specific to your prescribing relationship. If you want to stay on brand-name Wegovy with insurance coverage after leaving Sequence, your new provider would need to initiate a new prior authorization with your insurer. Ro Body has the strongest insurance navigation infrastructure among cash-pay GLP-1 telehealth platforms for this purpose. If prior authorization is denied or your new provider can't initiate one, you'd pay brand-name Wegovy at retail (~$1,349/month) or transition to compounded semaglutide at cash-pay rates. For most patients leaving Sequence for cost reasons, the move to compounded semaglutide on a cash-pay basis is the primary appeal.

References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
  2. Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed
  3. FDA. Wegovy (semaglutide) Prescribing Information. FDA.gov
  4. FDA. Human Drug Compounding — Section 503A. FDA.gov
  5. WeightWatchers. WW Clinic Program. weightwatchers.com
  6. NovoCare. Wegovy Savings Card. novocare.com
  7. NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
  8. NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
Medical Disclaimer: This guide is for educational purposes only. Luma Health competes with Sequence/WW Clinic. Do not discontinue GLP-1 medication without a replacement plan in place — treatment gaps can reverse progress. Switching from brand-name Wegovy to compounded semaglutide changes the medication format (pen to vial) and removes insurance coverage. Clinical services at Luma Health are provided by Wasef Health, PC. Compounded medications prepared by VialsRX, TX Board #35264.

© 2026 Luma Health — 2500 Quantum Lakes Drive, Boynton Beach, FL 33426

Clinical services provided by Wasef Health, PC. Compounded medications prepared by VialsRX (Houston, TX, 503A licensed).

Privacy Policy  |  Terms of Service  |  Blog